AB0462 Up to 5-Year Retention of Abatacept in Belgian Patients With Moderate-To-Severe Ra: Prospective Data From the Real-World Action Study

doi 10.1136/annrheumdis-2018-eular.1647
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Characterization of Insufficient Responders to Anti-Tumor Necrosis Factor Therapies in Patients With Moderate to Severe Psoriasis: Real-World Data From the US Corrona Psoriasis Registry

Journal of Dermatological Treatment
Dermatology
2019English

Better Retention of Abatacept Is Associated With High Rheumatoid Factor: A Five-Year Follow-Up Study of Patients With Rheumatoid Arthritis

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Psy149 - Iqvia Patient Data Assessment: Real World Evidence in the Management of Moderate-To-Severe Plaque Psoriasis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Factors Affecting the Success of Step-Up Therapy in Patients With Moderate-Severe Asthma: A Real-Life Study

Journal of Investigational Allergology and Clinical Immunology
AllergyImmunology
2019English

Prevalence of Glaucoma in Patients With Moderate to Severe Obstructive Sleep Apnea: Ocular Morbidity and Outcomes in a 3 Year Follow-Up Study

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2014English

Ustekinumab in Real-Life Practice: Experience in 116 Patients With Moderate-To-Severe Psoriasis

Acta Medica Portuguesa
Medicine
2019English

Living With Moderate to Severe Renal Failure From the Perspective of Patients

BMC Nephrology
Nephrology
2016English

Fifteen-Year Follow-Up of Upper Limb Function in Children With Moderate to Severe Traumatic Brain Injury

Journal of Rehabilitation Medicine
MedicinePhysical TherapySports TherapyRehabilitationSports Science
2013English

Decreased Use of Glucocorticoids in Biological-Experienced Patients With Rheumatoid Arthritis Who Initiated Intravenous Abatacept: Results From the 2-Year ACTION Study

RMD Open
RheumatologyAllergyImmunology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy